A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, August 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 418 followers.

Cancer Therapy News: A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patient... http://t.co/cbYhVPVg4Q

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.